2m 2m 2m 2m 2m 2m 2m
CORB PHRM HLDGS (CRBP)
NASDAQ
$7.65+$0.27 (+3.63%)
Price as of Jun 03, 2026 8:00 PM EDT- $146.6MMarket Cap
- -12.87%1-Year Change
- BiotechnologyIndustry
CORB PHRM HLDGS (CRBP)
$7.65+$0.27 (+3.63%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | -2.9M N/A | 0 -100.00% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 +100.00% | -2.9M N/A | 0 -100.00% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -70.1M +117.54% | -32.2M +3.38% | -31.2M +93.15% | -16.1M -55.72% | |
Depreciation and Amortization Expense | 233,000 -60.37% | 588,000 -8.21% | 640,601 -16.04% | 762,995 -23.69% | |
Total Operating Expenses | 85.3M +75.10% | 48.7M +8.08% | 45.1M +13.16% | 39.8M -29.95% | |
Operating Profit | -85.3M +75.10% | -48.7M +8.08% | -45.1M +13.16% | -39.8M -28.85% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | 0 +100.00% | -1.8M -38.44% | -2.9M +37.14% | -2.1M +16.48% | |
Interest Income and Expense and Net | 0 +100.00% | -1.8M -38.44% | -2.9M +37.14% | -2.1M +16.48% | |
Total Nonoperating Income and Expense | 6.8M -20.43% | 8.5M +1,695.84% | 473,985 +118.87% | -2.5M -124.27% | |
Income before Taxes | -85.3M +75.10% | -48.7M +8.08% | -45.1M +13.16% | -39.8M -28.85% | |
Income Taxes | 0 N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Net Income | -78.5M +95.32% | -40.2M -9.85% | -44.6M +5.33% | -42.3M -7.22% | |
Net Income from Continuing Operations Applicable to Common | -78.5M +95.32% | -40.2M -9.85% | -44.6M +5.33% | -42.3M -7.22% | |
Basic EPS and Net Income | -5.90 +60.33% | -3.68 -64.31% | -10.31 +1.58% | -10.15 +2,643.24% | |
Diluted EPS and Net Income | -5.90 +60.33% | -3.68 -64.31% | -10.31 +1.58% | -10.15 +2,643.24% | |
Basic Weighted Average Shares | 13.3M +22.00% | 10.9M +152.23% | 4.3M +3.76% | 4.2M -96.61% | |
Diluted Weighted Average Shares | 13.3M +22.00% | 10.9M +152.23% | 4.3M +3.76% | 4.2M -96.61% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 28.5M +65.67% | 17.2M +25.32% | 13.7M -19.29% | 17.0M -32.01% | |
Short-Term Investments | 134.8M +2.21% | 131.9M +1,735.95% | 7.2M -82.98% | 42.2M -41.91% | |
Cash and Cash Equivalents and Short-Term Investments | 163.3M +9.53% | 149.1M +613.01% | 20.9M -64.68% | 59.2M -39.38% | |
Total Current Assets | 167.0M +9.14% | 153.0M +549.69% | 23.5M -60.87% | 60.2M -39.94% | |
Accumulated Depreciation | 4.3M +5.72% | 4.1M +14.56% | 3.6M +14.94% | 3.1M +30.39% | |
Property and Plant and Equipment and Net | 159,000 -58.70% | 385,000 -60.44% | 973,214 -39.69% | 1.6M -32.55% | |
Total Long-Term Assets | 159,000 N/A | 0 -100.00% | 212,804 +36.99% | 155,346 +234.91% | |
Total Assets | 168.2M +7.90% | 155.9M +451.35% | 28.3M -57.36% | 66.3M -38.45% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 800,000 N/A | 0 -100.00% | 16.2M +414.73% | 3.1M -18.45% | |
Total Current Liabilities | 20.7M +75.09% | 11.8M -62.95% | 31.9M +152.33% | 12.6M -25.68% | |
Total Long-Term Debt | 20.0M N/A | 0 N/A | 0 -100.00% | 16.0M +2.23% | |
Total Long-Term Liabilities | 0 N/A | 0 -100.00% | 44,411 +100.00% | 22,205 0.00% | |
Total Liabilities | 20.7M +53.83% | 13.5M -61.76% | 35.2M +5.57% | 33.3M -13.72% | |
Retained Earnings | -555.4M +16.47% | -476.9M +9.21% | -436.7M +11.38% | -392.1M +12.11% | |
Total Stockholders Equity | 147.5M +3.56% | 142.4M +2,162.76% | -6.9M -120.93% | 33.0M -52.26% | |
Total Shares Outstanding | 17.6M +44.60% | 12.2M +175.32% | 4.4M +6.05% | 4.2M -96.67% | |
Cash Flow | |||||
Cash from Operating Activities | -64.5M +54.31% | -41.8M +15.77% | -36.1M -3.85% | -37.5M -22.08% | |
Capital Expenditures | 7,000 N/A | N/A N/A | 0 -100.00% | 13,449 -75.17% | |
Cash from Investing Activities | -1.6M -98.65% | -121.3M -440.36% | 35.6M +18.51% | 30.1M +140.96% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 77.4M -53.52% | 166.6M +6,005.93% | -2.8M +428.57% | -533,615 -100.88% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | 1,541.65% N/A | N/A N/A | |
Return on Assets | -48.47% +10.99% | -43.67% -53.70% | -94.31% +93.81% | -48.66% +11.97% | |
Return on Equity | -54.18% -8.70% | -59.34% -82.65% | -341.98% +312.26% | -82.95% +3.95% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | -100.00% +28.86% | |
Current Ratio | 8.07 -37.67% | 12.94 +1,653.26% | 0.74 -84.49% | 4.76 -19.19% | |
Cash Ratio | 1.38 -5.37% | 1.46 +238.18% | 0.43 -68.01% | 1.35 -8.51% | |
Debt-to-Equity Ratio | 0.14 N/A | 0.00 +100.00% | -2.35 -504.74% | 0.58 +105.60% | |
Debt-to-Assets Ratio | 0.12 N/A | 0.00 -100.00% | 0.57 +98.72% | 0.29 +59.39% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow